These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 29532427)

  • 21. Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies.
    Dodiya S; Chavhan S; Korde A; Sawant KK
    Drug Dev Ind Pharm; 2013 May; 39(5):733-43. PubMed ID: 22690834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
    Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
    Daru; 2011; 19(1):23-32. PubMed ID: 22615636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.
    Hamishehkar H; Ghanbarzadeh S; Sepehran S; Javadzadeh Y; Adib ZM; Kouhsoltani M
    Drug Dev Ind Pharm; 2016; 42(6):846-53. PubMed ID: 26154267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.
    Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S
    Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
    Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
    Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles.
    Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R
    Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sildenafil citrate as oral solid lipid nanoparticles: a novel formula with higher bioavailability and sustained action for treatment of erectile dysfunction.
    Hosny KM; Aljaeid BM
    Expert Opin Drug Deliv; 2014 Jul; 11(7):1015-22. PubMed ID: 24746063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical Amphotericin B solid lipid nanoparticles: Design and development.
    Butani D; Yewale C; Misra A
    Colloids Surf B Biointerfaces; 2016 Mar; 139():17-24. PubMed ID: 26700229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology.
    Sarangi B; Jana U; Sahoo J; Mohanta GP; Manna PK
    Biomed Microdevices; 2018 Jun; 20(3):53. PubMed ID: 29946758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design.
    Sharma JB; Bhatt S; Saini V; Kumar M
    Assay Drug Dev Technol; 2021; 19(4):262-279. PubMed ID: 34000202
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of olmesartan medoxomil lipid-based nanoparticles and nanosuspension: preparation, characterization and comparative pharmacokinetic evaluation.
    B A; D N; Veerabrahma K
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):126-137. PubMed ID: 28290712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats.
    Ansari MJ; Anwer MK; Jamil S; Al-Shdefat R; Ali BE; Ahmad MM; Ansari MN
    Drug Deliv; 2016 Jul; 23(6):1972-9. PubMed ID: 26017100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design.
    Hao J; Wang F; Wang X; Zhang D; Bi Y; Gao Y; Zhao X; Zhang Q
    Eur J Pharm Sci; 2012 Sep; 47(2):497-505. PubMed ID: 22820033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L; Tang X; Cui F
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV.
    Ansari H; Singh P
    Curr HIV Res; 2018; 16(4):270-279. PubMed ID: 30246641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability.
    Neves AR; Lúcio M; Martins S; Lima JL; Reis S
    Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
    Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
    J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.